Careers Header Bg
Regask Raps Convergence 2025 Landing Page
REGASK SPONSORS

RAPS Convergence 2025

OCTOBER 7-9, 2025  |  PITTSBURGH, PENNSYLVANIA

David L. Lawrence Convention Center | Booth #843

Meet us at RAPS Convergence 2025 Meet us at DIA Singapore 2025

Meet our team

Join Deanna Coscia, Senior Vice President, Commercial, Kelli Madden, Senior Regulatory Intelligence Manager, and Josh Lambeth, Senior Director, Business Development at RegASK as they represent us at RAPS Convergence 2025.

Visit us at Booth #843 to connect, explore AI-driven regulatory intelligence, and see how RegASK empowers smarter, faster compliance in dynamic life sciences markets.

Raps Chapter Atlanta 2025 Attendees

Josh Lambeth

Senior Director, Business Development

Deanna Coscia

SVP, Commercial

Kelli Madden

Senior Regulatory Intelligence Manager



Bg Flip Card 1

RAPS Convergence Pittsburgh 2025

RAPS Convergence 2025 is the largest annual gathering for regulatory affairs professionals, bringing together global leaders from pharmaceuticals, medical devices, diagnostics, regulatory bodies, and emerging technologies to shape the future of regulatory science and compliance.

Key themes include:

  • Advancing regulatory science across pharma, biotech, devices, and diagnostics
  • Global harmonization of regulatory frameworks and cross-border collaboration
  • Integration of AI and digital innovation in regulatory workflows
  • Strengthening post-market surveillance, labeling, and compliance strategies
  • Building leadership skills and professional development for regulatory professionals

Venue & Schedule:
📍 David L. Lawrence Convention Center, Pittsburgh, Pennsylvania, USA
🗓 October 6–9, 2025 | Preconference Workshops: Oct 6–7 | Main Conference: Oct 7–9


What RegASK Brings to RAPS Convergence

As a bronze sponsor of RAPS Convergence 2025, RegASK supports the global regulatory community by empowering teams with AI-driven regulatory intelligence and workflow orchestration. We help organizations monitor evolving regulations, streamline compliance, align global-to-local strategies, and mitigate risks with proactive insights, freeing teams to focus on innovation while navigating regulatory complexity with confidence and speed.

Meet us at RAPS Convergence 2025! Meet us at RAPS Convergence 2025!

Our solution

RegASK leverages advanced AI and machine learning to help businesses in highly regulated industries streamline their regulatory compliance processes and stay ahead of the curve. Our cutting-edge solution automates regulatory research, provides vital insights, and empowers regulatory affairs teams to become strategic partners in driving business growth.

Resources

Navigating a Potential U.S. Government Shutdown: Implic…
As legislators in Washington, DC, face a critical March 14th deadline to finalize federal spending, the possibility of a U.S. government shu…
Read more
RegASK Featured in Gartner’s Market Guide for Regulat…
We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …
Read more
The 2025 State of Regulatory Affairs and Compliance Rep…
Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more complex than ever, with new adv…
Read more
ANSM (France) Clarifies CE Mark Exemption Process for M…
On January 27, 2025, the National Security Agency of Medicines and Health Products (ANSM) in France issued a key update regarding the proces…
Read more
US FDA Announces Draft Guidance on AI Use in Regulatory…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of a draft guidance titled “Considerations for the U…
Read more
US FDA Announces Public Meeting on Paediatric Legislati…
The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting: Implementation of the Best Pharm…
Read more
FDA (USA) Establishes New Center for Real-World Evidenc…
On December 12, 2024, the U.S. Food and Drug Administration (FDA) announced the creation of the Center for Real-World Evidence and Innovatio…
Read more
Portuguese Industry Opposes U.S. Proposal for Cancer Wa…
The United States Health Authority is considering the introduction of mandatory cancer warning labels on alcoholic beverages, a measure simi…
Read more